US user fee bill gets Senate praise for fairness, set to proceed at last
This article was originally published in Clinica
Executive Summary
The US Congress reached agreement last week on a bill that would increase funding for speedier drug and device reviews at the Food and Drug Administration (FDA), as well as overhaul the FDA's drug safety programme.